Related Experiment Videos
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine
Monisha Madhumita1, Somesh Gupta2
1Department of Dermatology, Saveetha Medical College and Hospitals, Chennai, India; Department of Dermatology and Biomedical Research, Father Muller Medical College and Hospitals, Mangalore, India.
None:
Internal medicine involves high-stakes, time-sensitive decisions (such as triaging acute illnesses, escalating care, providing thromboprophylaxis, planning discharges, and managing chronic diseases) often under uncertainty. Risk stratification tools convert limited bedside data into actionable categories. Predictive analytics, by contrast, draws on richer electronic health record data streams to estimate short- or long-term risks in real time. Model performance varies across sites due to differences in data quality, outcome definitions, and workflows; external validation may reveal miscalibration, while alerts can cause alarm fatigue. This review provides a practical framework for clinicians and clinical leaders to appraise, select, and implement predictive models in internal medicine. We map common use cases (like inpatient deterioration, sepsis, acute kidney injury, venous thromboembolism, and readmission) to the clinical decisions they should trigger, emphasising that prediction without an intervention pathway rarely improves outcomes. We outline what to demand before deployment: a clearly specified target population and time horizon; predictor availability and measurement consistency; evaluation beyond discrimination to include calibration and decision-curve analysis; equity checks across key subgroups; and a life-cycle plan for monitoring dataset shift and calibration drift. We also discuss how we can choose thresholds, interpret probabilities at patient bedside and evaluate clinical impact with studies and continued monitoring. Recommendations are aligned with contemporary reporting and appraisal standards for prediction and AI studies (TRIPOD+AI, PROBAST+AI, CONSORT-AI, DECIDE-AI) and with governance and regulatory principles for AI-enabled medical software. The goal is to help internists translate risk scores and EHR-based predictions into safer, more equitable, and measurably effective care pathways. [1].
Related Concept Videos
Steps in Outbreak Investigation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...